glp-1pricelist
The transparent cost desk
Independent editorial information · not individual medical advice
Commercial pages may contain paid referral links. Compare the full payment terms and licensed-care details before enrollment.
⚠️ Compounded medications are not FDA-approved. Consult a licensed clinician before starting any GLP-1 therapy.
Coverage Guide
Cheapest GLP-1 for Sleep Apnea in 2026
Price verification — October 26, 2026
This article includes an older pricing snapshot. Older amounts, coupons and annual totals below are historical illustrations, not current checkout quotes.
- Wegovy (semaglutide): Wegovy tablet: $149/30 tablets at 1.5 mg, $199 at 4 mg (a temporary $149 4 mg offer may apply), and $299 at 9 mg or 25 mg. Wegovy injection: eligible new patients may pay $199 per 28-day fill for the first two fills at 0.25 or 0.5 mg through Dec. 31, 2026, then generally $349 for standard pen doses. Eligibility and dosage restrictions apply. Official source
- Zepbound (tirzepatide): LillyDirect self-pay: 2.5 mg starts at $299/28 days, 5 mg at $399, and 7.5 mg and above at $449 only with qualifying 45-day refill timing. Higher-dose prices can be higher when those conditions are not met. Supplies may cost extra. Official source
- Clinical program fees: Ivím lists a $74.99/month membership with medication billed separately. Sesame lists care from $59/month on a 12-month commitment; month-to-month costs more, and medication is separate. These are care fees, not all-inclusive drug prices. Official source
- Sesame annual-commitment terms: Official source.
These are manufacturer self-pay or listed care-fee examples, not one all-inclusive price or guaranteed prescription. Insurers, clinical visits, pharmacy choice, dosage, supplies, refill conditions and geography can change the amount due.
Updated April 2026
·
7 min read
💡 Bottom Line
If you have both sleep apnea and obesity, you may have access to GLP-1 coverage that weight-loss-only patients don't. Zepbound is the only GLP-1 FDA-approved for obstructive sleep apnea, and Medicare Part D can cover it NOW for this indication — no Bridge program needed. This is the cheapest path to brand-name tirzepatide for qualifying patients.
Most people know GLP-1 medications as weight loss drugs. But Zepbound (tirzepatide) received a second FDA approval for moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity — and this changes the insurance picture dramatically.
Why the OSA Indication Matters for Pricing
Medicare Part D is prohibited from covering weight loss drugs. But it CAN cover Zepbound when prescribed for sleep apnea. This means Medicare patients with OSA can access Zepbound through standard Part D coverage right now — without waiting for the July 2026 Bridge program.
The same principle applies to many commercial insurance plans that exclude weight loss drugs but cover medications for other FDA-approved indications.
Every Pricing Pathway for Sleep Apnea Patients
Historical price illustration from this article; not a verified October 2026 provider quote. Check the official pricing sources above. | Pathway | Monthly Cost | Requirements |
|---|
| Medicare Part D (OSA indication) | Varies by plan | OSA diagnosis + BMI ≥27 + Part D enrollment |
| Medicare Part D (with $2,100 cap) | ≤$175/mo avg | Annual out-of-pocket capped at $2,100 |
| Medicare GLP-1 Bridge (July 2026) | $50/mo | BMI ≥35 or BMI ≥27 with conditions |
| Commercial insurance + savings card | $25/mo | Plan covers Zepbound for OSA |
| LillyDirect vials (self-pay) | $299–449/mo | Valid prescription, no insurance needed |
| Compounded tirzepatide | $179–299/mo | No OSA diagnosis needed |
Do You Qualify?
To access Zepbound through the OSA pathway, you need:
- Confirmed OSA diagnosis — from a sleep study (polysomnography) or home sleep apnea test
- Moderate-to-severe OSA — typically defined as an Apnea-Hypopnea Index (AHI) of 15 or higher
- BMI of 27 or higher
- Prescription from a licensed provider specifying Zepbound for OSA (not weight loss)
📌 Undiagnosed Sleep Apnea Is Extremely Common
An estimated 80% of moderate-to-severe OSA cases are undiagnosed. If you're overweight and experience loud snoring, daytime sleepiness, or morning headaches, ask your doctor about a sleep study. A positive diagnosis could unlock insurance coverage for Zepbound that you can't get for weight loss alone.
Cash-Pay Alternatives
If insurance doesn't cover you through the OSA pathway, these providers offer compounded tirzepatide without requiring a sleep apnea diagnosis:
| Provider | Starting Price | Details |
|---|
Sponsored partner · current offerGobyMedsExplore available weight-management program types and confirm the exact medication, pharmacy and recurring charges.
Explore GobyMeds ↗Medication, legal availability, provider credentials and full price require verification; compounded medications are not FDA-approved. Sponsored partner · current offerHealthRX — semaglutideA listing for compounded semaglutide. Compounded medication is not FDA-approved; verify current lawful availability.
Explore HealthRX — semaglutide ↗Medication, legal availability, provider credentials and full price require verification; compounded medications are not FDA-approved. Sponsored partner · current offerBiltRxExplore GLP-1 care options and confirm formulation, pharmacy details, and full prices.
Explore BiltRx ↗Medication, legal availability, provider credentials and full price require verification; compounded medications are not FDA-approved. | Sprout Health | $229/mo | Check Price → Paid link |
Key Takeaways
- Zepbound is the only GLP-1 FDA-approved for sleep apnea
- Medicare Part D can cover Zepbound for OSA right now — no Bridge needed
- Commercial insurance + savings card: as low as $25/month
- 80% of moderate-to-severe OSA is undiagnosed — a sleep study could unlock coverage
- Cash-pay compounded tirzepatide from $179/month if insurance isn't an option
Compare All GLP-1 Prices
See today's lowest verified prices from vetted telehealth providers.
Compare Prices →
Paid link · Compounded medications are not FDA-approved.